These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8539933)

  • 1. Prevention and treatment of type I diabetes in NOD mice by linomide.
    Slavin S; Gross D; Weiss L
    Transplant Proc; 1995 Dec; 27(6):3240. PubMed ID: 8539933
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of autoimmune diabetes by linomide in nonobese diabetic (NOD) mice is associated with up-regulation of the TCR-mediated activation of p21(ras).
    Rapoport MJ; Weiss L; Mor A; Bistritzer T; Ramot Y; Slavin S
    J Immunol; 1996 Nov; 157(10):4721-5. PubMed ID: 8906854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of diabetes in NOD mice with advanced disease by islet isografts following immunoregulation with Linomide (quinoline-3-carboxamide).
    Slavin S; Weiss L; Xia W; Gross DJ
    Cell Transplant; 1996; 5(6):627-30. PubMed ID: 8951220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose dependence of bacillus Calmette-Guerin on the prevention of autoimmune diabetes in syngeneic islet transplantation.
    Lakey JR; Singh B; Warnock GL; Elliott JF; Rajotte RV
    Transplant Proc; 1995 Dec; 27(6):3413. PubMed ID: 8540025
    [No Abstract]   [Full Text] [Related]  

  • 5. Linomide, a new treatment for autoimmune diseases: the potential in type 1 diabetes.
    Slavin S; Sidi H; Weiss L; Rosenman E; Kalland T; Gross D
    Diabetes Metab Rev; 1993 Dec; 9(4):311-5. PubMed ID: 7924828
    [No Abstract]   [Full Text] [Related]  

  • 6. The immunomodulator Linomide: role in treatment and prevention of autoimmune diabetes mellitus.
    Gross DJ; Weiss L; Reibstein I; Hedlund G; Dahlén E; Rapoport MJ; Slavin S
    Int Immunopharmacol; 2001 Jun; 1(6):1131-9. PubMed ID: 11407307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine production in Linomide-treated nod mice and the potential role of a Th (1)/Th(2) shift on autoimmune and anti-inflammatory processes.
    Weiss L; Barak V; Zeira M; Abdul-Hai A; Raibstein I; Reich S; Hirschfeld E; Gross D; Slavin S
    Cytokine; 2002 Jul; 19(2):85-93. PubMed ID: 12182843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of diabetes mellitus in non-obese diabetic mice by Linomide, a novel immunomodulating drug.
    Gross DJ; Sidi H; Weiss L; Kalland T; Rosenmann E; Slavin S
    Diabetologia; 1994 Dec; 37(12):1195-201. PubMed ID: 7895948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syngeneic islets transplanted into the thymus of newborn mice prevent diabetes and reduce insulitis in the NOD mouse.
    Nomura Y; Mullen Y; Stein E
    Transplant Proc; 1993 Feb; 25(1 Pt 2):963-4. PubMed ID: 8442281
    [No Abstract]   [Full Text] [Related]  

  • 10. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of diabetes in nonobese diabetic mice with advanced disease by linomide-induced immunoregulation combined with Reg protein treatment.
    Gross DJ; Weiss L; Reibstein I; van den Brand J; Okamoto H; Clark A; Slavin S
    Endocrinology; 1998 May; 139(5):2369-74. PubMed ID: 9564847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
    Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
    J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation of autoimmunity by linomide.
    Karussis DM; Lehmann D; Slavin S; Kalland T; Vourka-Karussis U; Mizrachi-Koll R; Ovadia H; Abramsky O
    Isr J Med Sci; 1995 Jan; 31(1):38-41. PubMed ID: 7836046
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of Linomide on adhesion molecules, TNF-alpha, nitrogen oxide, and cell adhesion.
    Abdul-Hai A; Hershkoviz R; Weiss L; Lider O; Slavin S
    Int Immunopharmacol; 2005 Feb; 5(2):231-9. PubMed ID: 15652754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
    Reddy S; Cheung CC; Chai RC; Rodrigues JA
    Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with epidermal growth factor and gastrin delays autoimmune diabetes recurrence in nonobese diabetic mice transplanted with syngeneic islets.
    Suarez-Pinzon WL; Rabinovitch A
    Transplant Proc; 2008 Mar; 40(2):529-32. PubMed ID: 18374121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
    Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
    Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linomide does not prevent spontaneous autoimmune thyroiditis in NOD mice.
    Hartoft-Nielsen ML; Rasmussen AK; Kaas A; Bock T; Buschard K; Feldt-Rasmussen U
    Autoimmunity; 2001; 33(2):79-84. PubMed ID: 11264786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of recurrent but not spontaneous autoimmune diabetes by transplanted NOD islets adenovirally transduced with immunomodulating molecules.
    Sakata M; Yasuda H; Moriyama H; Yamada K; Kotani R; Kurohara M; Okumachi Y; Kishi M; Arai T; Hara K; Hamada H; Yokono K; Nagata M
    Diabetes Res Clin Pract; 2008 Jun; 80(3):352-9. PubMed ID: 18400329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversies on the prevention of insulin-dependent diabetes mellitus by immunomodulation: lessons from NOD mice treated with beta-1,6;1,3-D-glucan and rhIGF-I.
    Kida K; Kaino Y; Ito T; Hirai H
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():327-33. PubMed ID: 9642663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.